share_log

Reshape Lifesciences FY23 Sales $8.678M Miss $8.904M Estimate

Reshape Lifesciences FY23 Sales $8.678M Miss $8.904M Estimate

Reshape Lifesciences 23财年销售额为867.8万美元,未达到预期的890.4万美元
Moomoo 24/7 ·  04/01 16:08

Reshape Lifesciences (NASDAQ:RSLS) reported quarterly sales of $8.678 million which missed the analyst consensus estimate of $8.904 million by 2.54 percent.

Reshape Lifesciences(纳斯达克股票代码:RSLS)公布的季度销售额为867.8万美元,比分析师共识估计的890.4万美元低2.54%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发